TE Connectivity to present at Baird’s 2019 Global Industrial Conference

SCHAFFHAUSEN, Switzerland, Oct. 24, 2019 /PRNewswire/ — TE Connectivity Ltd. (NYSE: TEL), a world leader in connectivity and sensors, announced today that Chief Executive Officer Terrence Curtin will present at Baird’s 2019 Global Industrial Conference on Wednesday November 6, 2019, at 8:00 a.m. CT at the Four Seasons Hotel in Chicago.

A live audio webcast  of the conference will be available in the events section of TE Connectivity’s investor relations website at  investors.te.com. A replay of the webcast will be available for 90 days after the live presentation and can be accessed at the same website. 

About TE Connectivity

TE Connectivity Ltd. (NYSE: TEL) is a $14 billion global technology and manufacturing leader creating a safer, sustainable, productive, and connected future. For more than 75 years, our connectivity and sensor solutions, proven in the harshest environments, have enabled advancements in transportation, industrial applications, medical technology, energy, data communications, and the home. With 80,000 employees, including more than 8,000 engineers, working alongside customers in approximately 140 countries, TE ensures that EVERY CONNECTION COUNTS. Learn more at www.te.com and on LinkedInFacebook, WeChat and  Twitter.

View original content to download multimedia:http://www.prnewswire.com/news-releases/te-connectivity-to-present-at-bairds-2019-global-industrial-conference-300944636.html

SOURCE TE Connectivity Ltd.

user

Recent Posts

Laurel Bridge Software Advances Medical Imaging Workflow With New AI and Cloud Innovations at RSNA 2024

NEWARK, DE / ACCESSWIRE / November 22, 2024 / Laurel Bridge Software, a leader in…

23 minutes ago

Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)

DENVER, CO / ACCESSWIRE / November 22, 2024 / Aytu BioPharma, Inc. (the "Company" or…

23 minutes ago

Hemogenyx Pharmaceuticals PLC Announces Notice of Extraordinary General Meeting

Hemogenyx Pharmaceuticals plc("Hemogenyx Pharmaceuticals" or the "Company")Notice of Extraordinary General MeetingProposed Capital Reorganisation and New…

23 minutes ago

Sunshine Biopharma Launches a New Generic Prescription Drug

FORT LAUDERDALE, FL / ACCESSWIRE / November 22, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the…

23 minutes ago